Abstract
Aim: To evaluate the feasibility of ultrasound (US) computed tomography (CT) or magnetic resonance imaging (MRI) fusion imaging (FI) for localization and assessment of kidney lesions. Materials and Methods: Twenty-eight patients with kidney lesions previously detected on CT or MRI were included in this retrospective study. All 28 patients with kidney lesions, which were indefinable (42.9%) or hard to localize (57.1%) on gray-scale US alone, underwent FI of US with CT/MRI datasets. In 23 (82%) patients with indeterminate kidney lesions, FI including contrast-enhanced US was conducted. Results: FI was successfully performed in 25 out of 28 (89.3%) patients. FI with contrast-enhanced US was able to clarify the previously detected kidney lesions in 21 out of 23 patients (91.3%). Conclusion: FI is a feasible technique for localizing kidney lesions that are hard to define by grayscale US alone and the additional application of contrast-enhanced US is useful in clarifying indeterminate CT or MRI findings.
Author supplied keywords
Cite
CITATION STYLE
Auer, T., Heidegger, I., Zordo, T. D. E., Junker, D., Jaschke, W., Steinkohl, F., & Aigner, F. (2019). Fusion imaging of contrast-enhanced ultrasound with CT or MRI for kidney lesions. In Vivo, 33(1), 203–208. https://doi.org/10.21873/invivo.11460
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.